XIDARVO
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system diseases, neurological diseases, mood disorders, spinal cord injury, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
Abandoned · July 26, 2017 · 79218651 ·